거래량 | 0 |
|
|||||
뉴스 | - |
NantHealth Inc
시가총액 | 발행 주식 | Float | 매출 | 이익/손실 | EPS | 주가수익률 |
---|---|---|---|---|---|---|
155.99M | 115.55M | - | 67M | -67.78M | -0.59 | - |
공매도 잔량 | 주당 배당금 | 배당수익률 | 배당락일 | 인사이더 B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NantHealth 뉴스
일자 | 시간 | 출처 | 뉴스 기사 |
---|---|---|---|
23/04/2024 | 22:00 | Business Wire | NantHealth Welcomes Marc Harrison as Chief Legal Officer to.. |
10/04/2024 | 22:00 | Business Wire | NantHealth Strengthens Product Leadership Team to Drive.. |
30/01/2024 | 14:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
26/01/2024 | 07:21 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
26/01/2024 | 07:19 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
26/01/2024 | 07:17 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
03/01/2024 | 06:25 | Edgar (US Regulatory) | Form 8-K - Current report |
22/12/2023 | 07:04 | Edgar (US Regulatory) | Form 8-K - Current report |
02/11/2023 | 05:41 | Edgar (US Regulatory) | Form 8-K - Current report |
16/09/2023 | 07:32 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
14/09/2023 | 06:24 | Edgar (US Regulatory) | Form 8-K - Current report |
08/09/2023 | 06:27 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
NH 과거 가격 데이터
기간 | 시가 | 고가 | 저가 | VWAP | 평균 일일 거래량 | 변동 | % |
---|---|---|---|---|---|---|---|
1주 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1년 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3년 | 40.05 | 43.05 | 1.24 | 15.24 | 101,413 | -38.70 | -96.63% |
5년 | 8.325 | 99.00 | 1.24 | 42.39 | 367,303 | -6.98 | -83.78% |